军事知识服务平台
妊娠期高血压疾病合并妊娠期糖尿病对新生儿出生体重的影响
Effect of hypertensive disorders in pregnancy complicated with gestational diabetes mellitus on neonatal birth weight
摘要 目的:探讨妊娠期高血压疾病(HDP)合并妊娠期糖尿病(GDM)对新生儿出生体重的影响,为临床风险评估提供依据。方法:本研究依托2017年11月至2021年12月首都医科大学附属北京妇产医院牵头建立的中国出生人口队列(CBCS),排除多胎妊娠、妊娠28周前分娩以及分娩结局信息不全的孕妇后共纳入来自全国10个省级行政区14家医疗机构的132 626例孕妇。根据孕妇是否发生HDP和(或)GDM,分为对照组(100 335例)、HDP组(不合并GDM,7 219例)、GDM组(不合并HDP,22 229例)及HDP合并GDM组(2 843例)。比较各组孕妇的一般临床资料及妊娠结局,重点分析各组小于胎龄儿、大于胎龄儿、低出生体重儿及巨大儿的发生风险。采用logistic回归模型分析HDP、GDM和HDP合并GDM对新生儿出生体重的影响。结果:(1)本研究中HDP合并GDM的患病率为2.14%(2 843/132 626),HDP的患病率为7.59%(10 062/132 626),GDM的患病率为18.90%(25 072/132 626)。HDP合并GDM组孕妇的年龄、孕前体重指数(BMI)、辅助生殖受孕比例、剖宫产率均显著高于其他各组孕妇,中位分娩孕周显著低于其他各组孕妇(校正后 P均<0.008)。(2)校正孕妇年龄、孕前BMI等混杂因素后,HDP合并GDM组孕妇分娩小于胎龄儿的风险是对照组孕妇的3.56倍(95% CI为3.09~4.10, P<0.001);进一步调整分娩孕周后,HDP合并GDM组孕妇分娩低出生体重儿的风险是对照组孕妇的3.26倍(95% CI为2.74~3.88, P<0.001),分娩巨大儿的风险是对照组的1.33倍(95% CI为1.13~1.56, P=0.001)。(3)对新生儿体重的量化分析结果显示,总体孕妇中,与对照组相比,无论是否调整混杂因素,HDP合并GDM组和HDP组新生儿出生体重均显著降低,而GDM组的新生儿出生体重在调整混杂因素前升高、调整混杂因素后降低( P均<0.05)。与总体孕妇比较,早产孕妇中HDP组( β值分别为-188.10、-382.92 g)和HDP合并GDM组( β值分别为-147.43、-230.02 g)的新生儿出生体重均进一步降低。 结论:HDP合并GDM不仅增加低出生体重儿的发生风险,也增加巨大儿的发生风险,但其对新生儿尤其是早产儿出生体重的影响更接近于HDP的抑制生长效应。HDP合并GDM是具有高度异质性的复合型高危妊娠,临床应在规范血糖管理的同时,加强血压控制、胎盘功能评估、胎儿生长动态监测和早产风险管理,以改善母儿结局。
Abstract:
Objective:To investigate the effect of hypertensive disorders in pregnancy (HDP) complicated with gestational diabetes mellitus (GDM) on neonatal birth weight, and to provide a basis for clinical risk assessment.Methods:This study was based on the China Birth Cohort Study (CBCS), which was established from November 2017 to December 2021 by Beijing Obstetrics and Gynecology Hospital, Capital Medical University. A total of 132 626 pregnant women from 14 medical institutions in 10 provincial regions were included after excluding women with multiple pregnancies, delivery before 28 weeks of gestation, and those with incomplete information on delivery outcomes. According to the presence or absence of HDP and (or) GDM, pregnant women were divided into control group (100 335 cases), HDP group (without GDM, 7 219 cases), GDM group (without HDP, 22 229 cases) and HDP+GDM group (2 843 cases). The general clinical data and pregnancy outcomes of each group were compared, and the risks of small for gestational age (SGA), large for gestational age (LGA), low birth weight (LBW) and macrosomia were analyzed. Logistic regression model was used to analyze the effects of HDP, GDM and HDP combined with GDM on neonatal birth weight.Results:(1) The prevalence of HDP combined with GDM was 2.14% (2 843/132 626), the prevalence of HDP was 7.59% (10 062/132 626), and the prevalence of GDM was 18.90% (25 072/132 626). The age, pre-pregnancy body mass index (BMI), the proportion of assisted reproductive technology conception and cesarean section rate in the HDP+GDM group were significantly higher than those in the other groups, and the median gestational age at delivery was significantly lower than that in the other groups (all P<0.008 after adjustment). (2) After adjusting for confounding factors such as maternal age and pre-pregnancy BMI, the risk of SGA in HDP+GDM group was 3.56 times higher than that in the control group (95% CI: 3.09-4.10, P<0.001). After further adjustment for gestational age, the risks of LBW and macrosomia were 3.26 (95% CI: 2.74-3.88, P<0.001) and 1.33 (95% CI: 1.13-1.56, P=0.001) times higher in the HDP+GDM group than those in the control group. (3) Quantitative analysis of neonatal weight showed that in the overall cohort, compared with the control group, the birth weight of neonates in the HDP+GDM group and the HDP group were significantly lower regardless of confounding factors adjustment, while the birth weight of neonates in the GDM group increased before confounding factors adjustment and decreased after confounding factors adjustment (all P<0.05). Compared with the overall cohort, the neonatal birth weight of the HDP group ( β values were -188.10 and -382.92 g, respectively) and the HDP+GDM group ( β values were -147.43 and -230.02 g, respectively) were further reduced in the preterm birth cohort. Conclusions:HDP complicated with GDM not only increases the risk of LBW, but also increases the risk of macrosomia, but its effect on the birth weight of newborns, especially preterm infants, is more similar to the growth-inhibiting effect of HDP. HDP complicated with GDM is a complex high-risk pregnancy with high heterogeneity. In clinical practice, blood pressure control, placental function assessment, fetal growth dynamic monitoring and preterm birth risk management should be strengthened in addition to standardized blood glucose management to improve maternal and fetal outcomes.